Wuguang Chang

Dr. Wuguang Chang


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2022 in Genes
Verified
Journal Article
Open access
PDF file
WCWuguang Chang
Wuguang Chang
HLHongmu Li
Hongmu Li
CWChun Wu
Chun Wu
LZLeqi Zhong
Leqi Zhong
TZTengfei Zhu
Tengfei Zhu
SWSiyu Wang
Siyu Wang
Dysregulation of amino acid metabolism (AAM) is an important factor in cancer progression. This study intended to study the prognostic value of AAM-related genes in lung adenocarcinoma (LUAD). Methods: The mRNA expression profiles of LUAD datasets from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) were applied as the training and validation sets. After identifying the differentially expressed AAM-related genes, an AAM-related gene signature (AAMRGS) was constructed and validated. Additionally, we systematically analyzed the differences in immune cell infiltration, biological pathways, immunotherapy response, and drug sensitivity between the two AAMRGS subgroups. Results: The prognosis-related signature was constructed on the grounds of key AAM-related genes. LUAD patients were divided into AAMRGS-high and -low groups. Patients in the two subgroups differed in prognosis, tumor microenvironment (TME), biological pathways, and sensitivity to chemotherapy and immunotherapy. The area under the receiver operating characteristics (ROC) and calibration curves showed good predictive ability for the nomogram. Analysis of immune cell infiltration revealed that the TME of the AAMRGS-low group was in a state of immune activation. Conclusion: We constructed an AAMRGS that could effectively predict prognosis and guide treatment strategies for patients with LUAD.

20 November 2022 in Genes
Verified
Journal Article
Open access
PDF file
CWChun Wu
Chun Wu
HLHongmu Li
Hongmu Li
WCWuguang Chang
Wuguang Chang
LZLeqi Zhong
Leqi Zhong
ZLZhang Lin
Zhang Lin
SMShijuan Mai
Shijuan Mai
Background: Up frameshift protein 1 (UPF1) is a key component of nonsense-mediated mRNA decay (NMD) of mRNA containing premature termination codons (PTCs). The dysregulation of UPF1 has been reported in various cancers. However, the expression profile of UPF1 and its clinical significance in clear cell renal cell carcinoma (ccRCC) remains unclear. Methods: In order to detect UPF1 expression in ccRCC and its relationship with the clinical features of ccRCC, bulk RNA sequencing data were analyzed from The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and ArrayExpress databases. The impact of UPF1 on the immune microenvironment of ccRCC was evaluated by multiple immune scoring algorithms to identify the cell groups that typically express UPF1 using ccRCC single cell sequencing (scRNA) data. In addition, genes co-expressed with UPF1 were identified by the weighted gene correlation network analysis (WGCNA), followed by KEGG and Reactome enrichment analysis. A series of functional experiments were performed to assess the roles of UPF1 in renal cancer cells. Finally, pan-cancer analysis of UPF1 was also performed. Results: Compared with normal tissues, the expression levels of UPF1 mRNA and protein in tumor tissues of ccRCC patients decreased significantly. In addition, patients with low expression of UPF1 had a worse prognosis. Analysis of the immune microenvironment indicated that UPF1 immune cell infiltration was closely related and the ccRCC scRNA-seq data identified that UPF1 was mainly expressed in macrophages. WGCNA analysis suggested that the functions of co-expressed genes are mainly enriched in cell proliferation and cellular processes. Experimental tests showed that knockdown of UPF1 can promote the invasion, migration and proliferation of ccRCC cells. Lastly, pan-cancer analysis revealed that UPF1 disorders were closely associated with various cancer outcomes. Conclusions: UPF1 may play a tumor suppressive role in ccRCC and modulate the immune microenvironment. The loss of UPF1 can predict the prognosis of ccRCC, making it a promising biomarker and providing a new reference for prevention and treatment.

18 May 2026 in Frontiers in Genetics
Verified
Journal Article
Open access
XHXinyan Hu
Xinyan Hu
KWKunpeng Wei
Kunpeng Wei
PPPengfei Pang
Pengfei Pang
WCWuguang Chang
Wuguang Chang
LHLin Huang
Lin Huang
Background: Atherosclerosis is a long-term inflammatory disorder of the arterial wall, characterized by lipid deposition and infiltration of immune cells. Recent studies suggest that cuproptosis may participate in the progression of atherosclerosis. Methods: Multiple scRNA-seq and bulk RNA-seq datasets were integrated to systematically characterize cuproptosis patterns in atherosclerosis. Differential expression analysis based on cuproptosis scores identified cuproptosis-modulating genes, which were further refined using least absolute shrinkage and selection operator, decision tree, and XGBoost algorithms. CellChat analysis explored the effect of ARID1B expression on intercellular communication, while immune infiltration patterns were assessed via single-sample gene set enrichment analysis. ApoE −/− mice served as the in vivo model of atherosclerosis to confirmed relationships among cuproptosis, ARID1B expression, and immune infiltration in plaques. Results: Cuproptosis activity was significantly elevated in atherosclerotic tissues compared with normal arteries, with macrophages exhibiting the highest cuproptosis scores. Distinct expression profiles of cuproptosis-related genes, together with divergent immune infiltration landscapes, were observed between the high and low cuproptosis score atherosclerosis groups. ARID1B was identified as a gene discriminating cuproptosis status in atherosclerosis pathology, with significantly reduced expression in the disease group. Functional enrichment analyses suggested that ARID1B-associated networks were mainly involved in immune cell adhesion, activation, and differentiation. In vivo validation further confirmed that ARID1B expression was significantly reduced in the atherosclerosis group, which was associated with prominent T cell and macrophage infiltration. Conclusion: Cuproptosis-related gene ARID1B may reshape immune infiltration patterns in atherosclerosis, positioning it as a promising therapeutic target.